Abstract | AIM: In the present study quercetin was studied for its role in inflammation, oxidative stress markers and 5-HT levels in unpredictable chronic mild stress (UCMS) animal model of depression. MATERIALS AND METHODS: The mice were randomized into different groups trained for UCMS protocol followed by different drug treatments. Treatments were started after 2 weeks from the start of UCMS protocol and continued up to 6 weeks. The behavioral tests such as modified forced swimming (MFST), tail suspension (TST) and open field tests were performed on week 6, at least 24 h after the last drug treatment. Behavioral tests were preceded following animal sacrifice for biochemical estimations. RESULTS: A significant decrease in swimming, climbing times and increase in immobility time in MFST and TST was observed in UCMS group. Administration of quercetin (25 mg/kg per orally (p.o) reversed these times in MFST and TST. A decrease in no. of field crossing, time spent in centre and no. of rearing were observed in UCMS group. Quercetin reduced these observations in open field test. There was a decrease in superoxide dismutase (SOD), glutathione (GSH), catalase and 5 HT levels in the brain tissue. Quercetin treatment significantly augmented SOD, GSH, catalase and 5 HT levels. Glutamate, TNF-α and IL-6 levels were increased in UCMS group while quercetin decreased these cytokines. CONCLUSION:
|
Authors | Khadeeja Khan, Abul Kalam Najmi, Mohd Akhtar |
Journal | Drug research
(Drug Res (Stuttg))
Vol. 69
Issue 7
Pg. 392-400
(Jul 2019)
ISSN: 2194-9387 [Electronic] Germany |
PMID | 30296804
(Publication Type: Journal Article)
|
Copyright | © Georg Thieme Verlag KG Stuttgart · New York. |
Chemical References |
- Anti-Inflammatory Agents
- Antidepressive Agents
- Antioxidants
- Biomarkers
- Serotonin
- Quercetin
|
Topics |
- Animals
- Anti-Inflammatory Agents
(pharmacology, therapeutic use)
- Antidepressive Agents
(pharmacology, therapeutic use)
- Antioxidants
(pharmacology, therapeutic use)
- Behavior, Animal
(drug effects)
- Biomarkers
(analysis, metabolism)
- Brain
(drug effects, immunology, pathology)
- Depression
(drug therapy, etiology, pathology)
- Disease Models, Animal
- Humans
- Inflammation
(drug therapy, pathology)
- Male
- Mice
- Oxidative Stress
(drug effects)
- Quercetin
(pharmacology, therapeutic use)
- Serotonin
(analysis, metabolism)
- Stress, Psychological
(complications)
- Treatment Outcome
|